We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$47.8B
AUM Growth
-$2.34B
(-4.7%)
Cap. Flow
-$5.56B
Cap. Flow
% of AUM
-11.64%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
2,131
New
54
Increased
334
Reduced
1,616
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thomson Reuters
TRI
|
+$89.7M |
| 2 |
Fortinet
FTNT
|
+$69.3M |
| 3 |
Flowers Foods
FLO
|
+$37.9M |
| 4 |
Brown & Brown
BRO
|
+$28.6M |
| 5 |
Consolidated Edison
ED
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$626M |
| 2 |
Microsoft
MSFT
|
+$454M |
| 3 |
Apple
AAPL
|
+$414M |
| 4 |
Broadcom
AVGO
|
+$317M |
| 5 |
Amazon
AMZN
|
+$270M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Consumer Discretionary | 10.23% |
| 3 | Industrials | 9.49% |
| 4 | Communication Services | 9.26% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWO
1701
Two Harbors Investment
TWO
$1.27B
| $194K | ﹤0.01% |
19,672
-3,635
| -16% | -$36.6K |
|
|
PDM
1702
Piedmont Realty Trust
PDM
$1.22B
| $191K | ﹤0.01% |
21,264
-4,236
| -17% | -$34.1K |
|
1703
Zymeworks
ZYME
$1.68B
| $191K | ﹤0.01% |
11,201
-1,464
| -12% | -$21K |
|
|
KW
1704
DELISTED
Kennedy-Wilson Holdings
KW
| $190K | ﹤0.01% |
22,782
-4,194
| -16% | -$33.6K |
|
1705
New Mountain Finance
NMFC
$646M
| $189K | ﹤0.01% |
19,629
+839
| +4% | +$8.7K |
|
1706
NeoGenomics
NEO
$1.81B
| $188K | ﹤0.01% |
24,306
-4,503
| -16% | -$31.5K |
|
1707
FerroAtlántica
GSM
$628M
| $186K | ﹤0.01% |
40,884
+16,370
| +67% | +$70.1K |
|
1708
Xencor
XNCR
$1.44B
| $186K | ﹤0.01% |
15,827
-2,569
| -14% | -$22.3K |
|
1709
Ivanhoe Electric
IE
$1.43B
| $184K | ﹤0.01% |
14,674
-2,923
| -17% | -$28.9K |
|
|
DFTX
1710
Definium Therapeutics
DFTX
$5.73B
| $184K | ﹤0.01% |
15,592
-2,676
| -15% | -$25K |
|
1711
Liberty Latin America Class C
LILAK
$1.5B
| $183K | ﹤0.01% |
23,861
-4,437
| -16% | -$30.3K |
|
1712
Enviri
NVRI
$621M
| $183K | ﹤0.01% |
14,410
-2,650
| -16% | -$27.4K |
|
1713
RLJ Lodging Trust
RLJ
$1.87B
| $183K | ﹤0.01% |
25,396
-5,060
| -17% | -$38.1K |
|
1714
Wave Life Sciences
WVE
$1.12B
| $182K | ﹤0.01% |
24,835
-3,904
| -14% | -$31.6K |
|
1715
Integra LifeSciences
IART
$1.54B
| $181K | ﹤0.01% |
12,634
-2,332
| -16% | -$31.9K |
|
1716
Empire State Realty Trust
ESRT
$976M
| $181K | ﹤0.01% |
23,612
-4,705
| -17% | -$36K |
|
|
CIM
1717
Chimera Investment
CIM
$1.05B
| $180K | ﹤0.01% |
13,617
-2,711
| -17% | -$37.7K |
|
1718
ImmunityBio
IBRX
$7.44B
| $180K | ﹤0.01% |
73,006
-7,122
| -9% | -$18.3K |
|
|
AIV
1719
Aimco
AIV
$380M
| $179K | ﹤0.01% |
22,585
-4,499
| -17% | -$36.5K |
|
1720
Spyre Therapeutics
SYRE
$8.87B
| $179K | ﹤0.01% |
10,678
-1,801
| -14% | -$29.4K |
|
1721
EyePoint Inc
EYPT
$1.02B
| $178K | ﹤0.01% |
12,490
-2,792
| -18% | -$32.1K |
|
1722
Trevi Therapeutics
TRVI
$2.49B
| $177K | ﹤0.01% |
19,322
-33
| -0.2% | -$247 |
|
1723
Arcus Biosciences
RCUS
$3.57B
| $177K | ﹤0.01% |
12,990
-2,375
| -15% | -$24.7K |
|
|
HPP
1724
Hudson Pacific Properties
HPP
$834M
| $176K | ﹤0.01% |
9,089
-274
| -3% | -$5.17K |
|
1725
Ecovyst
ECVT
$1.36B
| $176K | ﹤0.01% |
20,035
-2,114
| -10% | -$18.6K |
|
Similar funds
ProShare Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, ProShare Advisors held 2,131 positions worth $47.8B, down 4.7% from $50.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors withdrew a net $5.56B in Q3 2025, closing 126 positions and reducing 1,616 holdings. Its most notable exit was Ansys, an estimated $48.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, ProShare Advisors opened a new position in Thomson Reuters worth $75.8M.
- ProShare Advisors's largest Q3 2025 buy was Thomson Reuters: 480,707 shares worth $75.8M.
- ProShare Advisors added most to Fortinet in Q3 2025, an estimated $69.3M increase.
- ProShare Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $626M.
- ProShare Advisors fully exited Ansys in Q3 2025, selling an estimated $48.7M.
- ProShare Advisors's ten largest holdings make up 32% of its $47.8B portfolio in Q3 2025.
- ProShare Advisors opened 54 new positions and closed 126 in Q3 2025.
- ProShare Advisors's portfolio value fell 4.7% quarter-over-quarter to $47.8B.
Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.